Zimmer Biomet Holdings, Inc. Financials

Market Capitalization $17.84 Billion as of Jan. 1, 2026

Valuations Metrics as of Jan. 3, 2026

Trailing PE	22.31
Forward PE	10.57
Price to Sales TTM	$2.22
Price to Book MRQ	$1.40
Enterprise to Revenue	3.09
Enterprise to EBITDA	9.38

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-09-30
Profit Margin	10.05%
Operating Margin	17.00%
Return on Assets TTM	4.33%
Return on Equity TTM	6.42%

Income Statement

Revenue TTM	$8,010,899,968
Revenue per Share TTM	$40.35
Quarterly Revenue Growth	9.70%
Gross Profit TTM	$5,737,699,840
EBITDA	$2,542,600,000
Net Income to Common TTM	$805,299,968
Diluted EPS TTM	$4.03
Quarterly Earnings Growth YoY	-7.30%

Balance Sheet

Total Cash MRQ	$1,306,099,968
Total Cash per Share MRQ	$6.59
Total Debt MRQ	$
Total Debt to Equity MRQ	64.52
Current Ratio MRQ	2.43
Book Value per Share MRQ	$64.36

Cash Flow

Operating Cash Flow TTM	$1,686,000,000
Levered Free Cash Flow TTM	$1,169,887,488

ZBH Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding	198,200,000
Float Shares	197,709,883
Avg 10 Volume	1,642,430
Avg 30 Volume	None
Shares Short	7,772,345
Short Ratio	3.55
Short % of Shares	4.50%
% Held by Insiders	0.15%
% Held by Institutions	100.36%

Stock Price Summary

Beta	0.61
Fifty Two Week Low	$85.33
Fifty Two Week High	$114.44
Fifty Two Week Change	-15.04%
Day 50 MA	$93.93
Day 200 MA	$97.73

Dividends and Splits

Forward Annual Dividend Rate	$0.96
Forward Annual Dividend Yield	1.07%
Trailing Annual Dividend Rate	$0.96
Trailing Annual Dividend Yield	1.07%
Payout Ratio	23.82%
Dividend Date	2026-01-30
Ex Dividend Date	2025-12-30
Last Split Factor
Last Split Date	2022-03-01